<DOC>
	<DOC>NCT01033383</DOC>
	<brief_summary>This study will investigate whether there is a particular dose of cranberry capsules that is effective in preventing the occurrence of urinary tract infections in females at least 65 years of age or older who live in a nursing home and who have a history of urinary tract infections. The Yale research team will be enrolling 80 subjects in total over several nursing home locations within Connecticut.</brief_summary>
	<brief_title>Dosing Study of Cranberry Capsules for the Prevention of Bacteriuria in Nursing Home Residents</brief_title>
	<detailed_description>Each subject was enrolled after providing a baseline urine specimen. Cranberry/placebo capsules were consumed for 30 days. Urine specimens were obtained weekly for 4 weeks.</detailed_description>
	<mesh_term>Bacteriuria</mesh_term>
	<criteria>Female nursing home residents 65 years of age or older with history of urinary tract infection within the past year. residents that are not expected to be in the nursing home for at least one month (i.e., short term rehabilitation, pending discharge, terminal [life expectancy &lt; 1 month]); residents who are on chronic suppressive antibiotic or antiinfective (i.e., mandelamine) therapy for recurrent UTI; residents with end stage renal disease on dialysis (they do not regularly produce urine); residents unable to produce a baseline clean catch urine specimen for collection; residents on warfarin therapy because of a potential interaction of warfarin and cranberry juice; residents with a history of nephrolithiasis because cranberry may increase the risk of nephrolithiasis.</criteria>
	<gender>Female</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>